-- Hasten obtains rights to develop and commercialize lerodalcibep in Chinese Mainland, Hong Kong, Macau, and Taiwan and will be responsible for clinical development and regulatory approval in these territories
On July 11th, the "2023 Beijing International Life and Health Industry Cross-border Expo, Life and Health Innovators Annual Conference" was officially opened at the China International Exhibition Center in Beijing. With the theme of "4D Rules of Innovation Track", the branch ceremony, “Life and Health Innovators Annual Conference" organized by SiqiQuan, was launched there simultaneously.
The jointly organized by China Pharmaceutical Business Association and Sinopharm Global Procurement and Supply Chain Service Center was held in Shanghai recently. Mr. Kevin Gu, Senior Vice President, Head of Market Access, Commercial Diversity & International Business of Hasten Biopharmaceutical Co., Ltd. was invited to attend the conference and delivered a speech on "Exploring Supply Chain Integration Development for Innovative Pharmaceutical Enterprises".
Shanghai, May 4th , 2023 – Hasten Biopharmaceutic Co., Ltd (China) ("Hasten") today announced that it has acquired the commercial rights in China for Rocephin®, a long-acting, broad spectrum cephalosporin antibiotic, from Swiss multinational healthcare company, Roche.
20 April, 2023 – CBC Group (“CBC”), Asia’s largest healthcare-dedicated investment firm headquartered in Singapore, and Hasten Biopharmaceutic Company Limited (“Hasten”), today jointly announced the completion of a US$315 million fundraising round for Hasten. Hasten is an innovation-driven pharmaceutical company backed by CBC, Hefei Industry Investment Group, and Feidong County of Hefei City.
The year of 2022 marked the 70th anniversary of the Patriotic Health Movement (Be shorted as ‘the movement’). On December 27, the 2022 National Patriotic Health Campaign Conference, with the theme of "70 years’ Patriotic Health Movement, Healthy China Tour - advocating a civilized, healthy, sustainable and environmental lifestyle, and helping to normalize epidemic prevention and control", was successfully held in Beijing.
公司地址:这里是公司地址后期需要替换设计占位后台可替换
企业邮箱:infu@singlera.com.cn
联系电话:+86-8888-8888
商务联系:BD@singlera.com.cn
人力资源:HR@singlera.com.cn